The DOI matches its Crossref record; 255 of the 258 references it cites were found in a registry or an index.
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Abstract
Numerous lines of inquiry implicate connectivity as a central abnormality in schizophrenia. Myelination and factors that affect myelination, such as the function of oligodendroglia, are critical processes that could profoundly affect neuronal connectivity, especially given the diffuse distribution of oligodendrocytes and the widespread distribution of brain regions that have been implicated in schizophrenia. Multiple lines of evidence now converge to implicate oligodendroglia and myelin in schizophrenia. Imaging and neurocytochemical evidence, similarities with demyelinating diseases, age-related changes in white matter, myelin-related gene abnormalities, and morphologic abnormalities in the oligodendroglia demonstrated in schizophrenic brains are all examined in light of the hypothesis that oligodendroglial dysfunction and even death, with subsequent abnormalities in myelin maintenance and repair, contribute to the schizophrenic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In schizophrenia, a severe mental illness characterized by positive (e.g., hallucinations and delusions) and negative (e.g., anhedonia and flat affect) symptoms, axon disruption with concurrent reduced myelin levels and oligodendrocyte abnormalities has been postulated as a key pathology based on both imaging and postmortem studies (Davis et al., 2003;Vikhreva et al., 2016).”
From NODDI in clinical research (2020) · cites this paper as Davis et al., 2003
In the citing paper
“Oligodendrocytes and myelination are clearly impaired in schizophrenia (Chew et al., 2013; Davis et al., 2003; Takahashi et al., 2011).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Davis et al., 2003
Citations
Cites
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
The Molecular Biology of Axon Guidance
Tessier‐Lavigne, M., & Goodman, C. S. (1996) · Science · doi:10.1126/science.274.5290.1123 · Cited by 3,311
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,329
Cognitive dysfunction in multiple sclerosis.
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. W. (1991) · Neurology · doi:10.1212/wnl.41.5.685 · Cited by 2,136
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,107
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Glutamate neurotoxicity in cortical cell culture
Choi, D. W., Maulucci-Gedde, M., & Kriegstein, A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,506
Cited by
Sorted by citations
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
Mueser, K. T., & McGurk, S. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16458-1 · Cited by 876
The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
Fatemi, S. H., & Folsom, T. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn187 · Cited by 860
Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia
Douaud, G., Smith, S. M., Jenkinson, M., Behrens, T. E. J., Johansen‐Berg, H., Vickers, J., James, S., Voets, N., Watkins, K. E., Matthews, P. M., et al. (2007) · Brain · doi:10.1093/brain/awm184 · Cited by 781
A review of diffusion tensor imaging studies in schizophrenia
Kubicki, M., McCarley, R., Westin, C.-F., Park, H.-J., Maier, S., Kikinis, R., Jolesz, F. A., & Shenton, M. E. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.05.005 · Cited by 769
A revised limbic system model for memory, emotion and behaviour
Catani, M., Dell’Acqua, F., & de Schotten, M. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.001 · Cited by 813
Prolonged myelination in human neocortical evolution
Miller, D. J., Duka, T., Stimpson, C. D., Schapiro, S. J., Baze, W. B., McArthur, M. J., Fobbs, A. J., Sousa, A. M. M., Šestan, N., Wildman, D. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117943109 · Cited by 699
Self-citationNeuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Kelly, S., Jahanshad, N., Zalesky, A., Kochunov, P., Agartz, I., Alloza, C., Andreassen, O. A., Arango, C., Banaj, N., Bouix, S., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.170 · Cited by 701
Harrison, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1761-y · Cited by 693
The environment and susceptibility to schizophrenia
Brown, A. S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.003 · Cited by 664
Neural synchrony indexes disordered perception and cognition in schizophrenia
Spencer, K., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., Shenton, M. E., & McCarley, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406074101 · Cited by 601
Yendiki, A. (2011) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2011.00023 · Cited by 590
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508
The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum
Siever, L. J., & Davis, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.398 · Cited by 510
Self-citationAndreassen, O. A., Djurovic, S., Thompson, W. K., Schork, A. J., Kendler, K. S., O’Donovan, M. C., Rujescu, D., Werge, T., van de Bunt, M., Morris, A. P., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.001 · Cited by 506
Schmahmann, J. D., Smith, E. E., Eichler, F., & Filley, C. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.017 · Cited by 512
Alexander-Bloch, A. F., Gogtay, N., Meunier, D., Birn, R., Clasen, L., Lalonde, F., Lenroot, R., Giedd, J., & Bullmore, E. T. (2010) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2010.00147 · Cited by 480
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
Horáček, J., Bubeníková‐Valešová, V., Kopeček, M., Páleníček, T., Dockery, C. A., Mohr, P., & Höschl, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00004 · Cited by 467
Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology
Harrison, P. J., & Law, A. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.002 · Cited by 472
Axonal regulation of myelination by neuregulin 1
Nave, K., & Salzer, J. L. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.08.008 · Cited by 461
Hof, P. R., Haroutunian, V., Friedrich, V. L., Byne, W., Buitron, C., Perl, D. P., & Davis, K. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00237-3 · Cited by 433
Self-citationDorph‐Petersen, K., Pierri, J. N., Perel, J. M., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300710 · Cited by 438
Bora, E., Fornito, A., Raduà, J., Walterfang, M., Seal, M. L., Wood, S. J., Yücel, M., Velakoulis, D., & Pantelis, C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.020 · Cited by 440
Brinkmann, B. G., Agarwal, A., Sereda, M. W., Garratt, A. N., Müller, T. H., Wende, H., Stassart, R. M., Nawaz, S., Humml, C., Velanac, V., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.028 · Cited by 440
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 430
Polarized Domains of Myelinated Axons
Salzer, J. L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00628-7 · Cited by 416
Support for the involvement of large copy number variants in the pathogenesis of schizophrenia.
Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K. K., Holmans, P., International Schizophrenia Consortium, the Wellcome Trust Case Control Consortium, Craddock, N., Owen, M. J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp043 · Cited by 390
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
Corfas, G., Roy, K., & Buxbaum, J. D. (2004) · Nature Neuroscience · doi:10.1038/nn1258 · Cited by 388
Self-citationMcDonald, C., Bullmore, E. T., Sham, P. C., Chitnis, X., Wickham, H., Bramon, E., & Murray, R. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.974 · Cited by 379
Andreasen, N. C., Nopoulos, P., Magnotta, V. A., Pierson, R. K., Ziebell, S., & Ho, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.017 · Cited by 376
Altered Functional and Anatomical Connectivity in Schizophrenia
Camchong, J., MacDonald, A. W., Bell, C., Mueller, B. A., & Lim, K. O. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp131 · Cited by 371
Hulshoff Pol, H. E., & Kahn, R. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm168 · Cited by 364
Evolution of increased glia–neuron ratios in the human frontal cortex
Sherwood, C. C., Stimpson, C. D., Raghanti, M. A., Wildman, D. E., Uddin, M., Grossman, L. I., Goodman, M., Redmond, J. C., Bonar, C. J., Erwin, J. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605843103 · Cited by 342
Self-citationHerbet, G., Zemmoura, I., & Duffau, H. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00077 · Cited by 296
Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia
Takahashi, N., Sakurai, T., Davis, K. L., & Buxbaum, J. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.004 · Cited by 337
Self-citationThe molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O’Donovan, M. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 328
Altar, C. A., Jurata, L. W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., Young, T. A., Bullard, J., Yokoe, H., Webster, M. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.031 · Cited by 318
Neuroinflammation and white matter pathology in schizophrenia: systematic review
Najjar, S., & Pearlman, D. M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.041 · Cited by 321
Chisholm, K., Lin, A. P., Abu-Akel, A. M., & Wood, S. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.012 · Cited by 347
Neuroinflammation in schizophrenia especially focused on the role of microglia
Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314
Critical period revisited: impact on vision
Morishita, H., & Hensch, T. K. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.05.009 · Cited by 311
Excessive Extracellular Volume Reveals a Neurodegenerative Pattern in Schizophrenia Onset
Pasternak, O., Westin, C., Sylvain Bouix, A., Seidman, L. J., Goldstein, J. M., Woo, T.-U. W., Petryshen, T. L., Mesholam‐Gately, R. I., McCarley, R. W., Kikinis, R., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2904-12.2012 · Cited by 306
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy
Friedman, J. I., Vrijenhoek, T., Markx, S., Janssen, I. M., van der Vliet, W. A., Faas, B. H. W., Knoers, N. V. A. M., Cahn, W., Kahn, R. S., Edelmann, L. J., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002049 · Cited by 297
Self-citationPrenatal Nutritional Deficiency and Risk of Adult Schizophrenia
Brown, A. S., & Susser, E. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn096 · Cited by 290
Kamiya, K., Hori, M., & Aoki, S. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108908 · Cited by 283
“pathology based on both imaging and postmortem studies (Davis et al., 2003; Vikhreva et al., 2016).”
The involvement of Reelin in neurodevelopmental disorders
Folsom, T. D., & Fatemi, S. H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.015 · Cited by 275
Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262
Excitotoxic damage to white matter
Matute, C., Alberdi, E. M., Domercq, M., Sánchez‐Gómez, M. V., Pérez‐Samartín, A., Antigüedad, A. R., & Pérez‐Cerdá, F. (2007) · Journal of Anatomy · doi:10.1111/j.1469-7580.2007.00733.x · Cited by 263
Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia
Windrem, M. S., Osipovitch, M., Liu, Z., Bates, J., Chandler-Militello, D., Zou, L., Munir, J., Schanz, S. J., McCoy, K., Miller, R. H., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.06.012 · Cited by 259
Wrapped to Adapt: Experience-Dependent Myelination
Mount, C., & Monje, M. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.009 · Cited by 262
The thalamus and schizophrenia: current status of research
Byne, W. M., Hazlett, E. A., Buchsbaum, M. S., & Kemether, E. M. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0404-0 · Cited by 254
Self-citationIwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama‐Shigeno, Y., Yoshikawa, T., & Kato, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0766-05.2005 · Cited by 241
Szeszko, P. R., Robinson, D. G., Ashtari, M., Vogel, J., Betensky, J. D., Sevy, S. M., Ardekani, B. A., Lencz, T., Malhotra, A. K., McCormack, J., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301480 · Cited by 241
Samartzis, L., Dima, D., Fusar‐Poli, P., & Kyriakopoulos, M. (2014) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2012.00779.x · Cited by 236
Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage
Kochunov, P., & Hong, L. E. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu070 · Cited by 236
Bechter, K., Reiber, H., Herzog, S., Fuchs, D., Tumani, H., & Maxeiner, H. G. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.008 · Cited by 235
Karlsgodt, K. H., Niendam, T. A., Bearden, C. E., & Cannon, T. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.013 · Cited by 229
Katsel, P., Davis, K. L., & HAROUTUNIAN, V. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.007 · Cited by 222
Self-citationLieberman, J. A., Bymaster, F. P., Meltzer, H. Y., Deutch, A. Y., Duncan, G. E., Marx, C. E., Aprille, J. R., Dwyer, D. S., Li, X., Mahadik, S. P., et al. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00107 · Cited by 225
Nesvåg, R., Lawyer, G., Varnäs, K., Fjell, A. M., Walhovd, K. B., Frigessi, A., Jönsson, E. G., & Agartz, I. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.015 · Cited by 226
Schizophrenia and the inferior parietal lobule
Torrey, E. F. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.023 · Cited by 216
Identifying blood biomarkers for mood disorders using convergent functional genomics
Le-Niculescu, H., Kurian, S. M., Yehyawi, N., Dike, C., Patel, S. D., Edenberg, H. J., Tsuang, M. T., Salomon, D. R., Nürnberger, J. I., & Niculescu, A. B. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.11 · Cited by 208
Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy
Bernstein, H., Steiner, J. H., Guest, P. C., Dobrowolny, H., & Bogerts, B. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.035 · Cited by 203
Maternal Iron Deficiency and the Risk of Schizophrenia in Offspring
Insel, B. J., Schaefer, C. A., McKeague, I. W., Susser, E., & Brown, A. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1136 · Cited by 202
Vierling-Claassen, D., Siekmeier, P. J., Stufflebeam, S. M., & Kopell, N. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00870.2007 · Cited by 200
Disturbed Structural Connectivity in Schizophrenia Primary Factor in Pathology or Epiphenomenon?
Konrad, A., & Winterer, G. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm034 · Cited by 202
Volume, neuron density and total neuron number in five subcortical regions in schizophrenia
Kreczmański, P., Heinsen, H., Mantua, V., Woltersdorf, F., Masson, T., Ulfig, N., Schmidt‐Kastner, R., Korr, H., Steinbusch, H. W. M., Hof, P. R., et al. (2007) · Brain · doi:10.1093/brain/awl386 · Cited by 196
Self-citationRegional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder
McDonald, C., Bullmore, E. T., Sham, P. C., Chitnis, X. A., Suckling, J., MacCabe, J. H., Walshe, M., & Murray, R. M. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.5.369 · Cited by 198
Szeszko, P. R., Ardekani, B. A., Ashtari, M., Kumra, S., Robinson, D. G., Sevy, S. M., Gunduz‐Bruce, H., Malhotra, A. K., Kane, J. M., Bilder, R. M., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.602 · Cited by 191
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy
Bernstein, H., Steiner, J. H., & Bogerts, B. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.59 · Cited by 192
Jelescu, I. O., Zurek, M., Winters, K. V., Veraart, J., Rajaratnam, A., Kim, N. S., Babb, J. S., Shepherd, T. M., Novikov, D. S., Kim, S. G., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.004 · Cited by 188
A putative functional role for oligodendrocytes in mood regulation
Edgar, N. M., & Sibille, E. L. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.34 · Cited by 191
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Labrie, V., Fukumura, R., Rastogi, A., Fick, L. J., Wang, W., Boutros, P. C., Kennedy, J. L., Semeralul, M. O., Lee, F. H., Baker, G. B., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp261 · Cited by 193
Altered white matter microstructure in adolescent substance users
Bava, S., Frank, L. R., McQueeny, T. M., Schweinsburg, B. C., Schweinsburg, A. D., & Tapert, S. F. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.04.005 · Cited by 182
Modeling the outcome of structural disconnection on resting-state functional connectivity
Cabral, J., Hugues, E., Kringelbach, M. L., & Deco, G. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.007 · Cited by 182
Stachowiak, E. K., Benson, C. A., Narla, S. T., Dimitri, A., Chuye, L. E. B., Dhiman, S., Harikrishnan, K., Elahi, S., Freedman, D., Brennand, K. J., et al. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0054-x · Cited by 179
Regenold, W. T., Phatak, P., Marano, C. M., Gearhart, L., Viens, C. H., & Hisley, K. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.019 · Cited by 178
Diffusion Tensor Imaging in Psychiatric Disorders
White, T. J. H., Nelson, M., & Lim, K. O. (2008) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3181809f1e · Cited by 177
Dracheva, S. M., Davis, K. L., Chin, B., Woo, D. A., Schmeidler, J., & Haroutunian, V. H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.012 · Cited by 178
Self-citationUranova, N. A., Vikhreva, O. V., Rachmanova, V. I., & Orlovskaya, D. D. (2011) · Schizophrenia Research and Treatment · doi:10.1155/2011/325789 · Cited by 173
The node of Ranvier in CNS pathology
Arancibia-Carcamo, I. L., & Attwell, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1305-z · Cited by 177
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi‐Gulyás, É., Eberlin, M. N., Souza, G. H. M. F., Marangoni, S., Novello, J. C., Turck, C. W., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.006 · Cited by 176
Lee, S.-H., Kubicki, M., Asami, T., Seidman, L. J., Goldstein, J. M., Mesholam-Gately, R. I., McCarley, R. W., & Shenton, M. E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.029 · Cited by 176
Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
Voineskos, A. N., Foussias, G., Lerch, J. P., Felsky, D., Remington, G. J., Rajji, T. K., Lobaugh, N. J., Pollock, B. G., & Mulsant, B. H. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.786 · Cited by 176
Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro
Kato, T. A., Monji, A., Hashioka, S., & Kanba, S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.019 · Cited by 173
Ashtari, M., Cottone, J. G., Ardekani, B. A., Cervellione, K. L., Szeszko, P. R., Wu, J., Chen, S., & Kumra, S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1270 · Cited by 175
Whitford, T. J., Kubicki, M. R., Schneiderman, J. S., O’Donnell, L. J., King, R., Alvarado, J. L., Khan, U., Markant, D. B., Nestor, P. G., Niznikiewicz, M. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.025 · Cited by 167
Associations of Cortical Thickness and Cognition in Patients With Schizophrenia and Healthy Controls
Ehrlich, S., Brauns, S., Yendiki, A., Ho, B., Calhoun, V. D., Schulz, S. C., Gollub, R. L., & Sponheim, S. R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr018 · Cited by 166
Yamada, K., Gerber, D. J., Iwayama, Y., Ohnishi, T., Ohba, H., Toyota, T., Aruga, J., Minabe, Y., Tonegawa, S., & Yoshikawa, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610765104 · Cited by 163
Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat
Wang, H.-D., Dunnavant, F. D., Jarman, T., & Deutch, A. Y. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300449 · Cited by 165
Sun, H., Lui, S., Li, Y., Deng, W., Xiao, Y., Zhang, W., Huang, X., Hu, J., Bi, F., Li, T., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0505 · Cited by 161
Evidence for white matter abnormalities in schizophrenia
Kubicki, M. R., McCarley, R. W., & Shenton, M. E. (2005) · Current Opinion in Psychiatry · doi:10.1097/00001504-200503000-00004 · Cited by 160
Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use
Ashtari, M., Cervellione, K., Cottone, J., Ardekani, B. A., & Kumra, S. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.002 · Cited by 159
Glial calcium and diseases of the nervous system
Nedergaard, M., Rodriguez, J. J., & Verkhratsky, A. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.11.010 · Cited by 163
The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions
Rotarska-Jagiela, A., Schönmeyer, R., Oertel, V., Haenschel, C., Vogeley, K. T., & Linden, D. E. J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.063 · Cited by 157
Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158
Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
Gray matter myelination of 1555 human brains using partial volume corrected MRI images
Shafee, R., Buckner, R. L., & Fischl, B. R. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.10.054 · Cited by 158
Metadata
- Authors
- Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2003-05-01
- Volume
- 60
- Issue
- 5
- Pages
- 443
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2049973822
- Cited by
- 793
- References
- 258
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 20 · 2023: 11 · 2022: 17 · 2021: 14 · 2020: 25 · 2019: 35 · 2018: 28 · 2017: 27 · 2016: 36 · 2015: 41 · 2014: 34 · 2013: 32 · 2012: 50
- FWCI
- 24.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- schizophrenia, white matter, myelination, oligodendrocytes, myelin, neuronal connectivity, demyelinating disease, oligodendrocyte dysfunction, age-related white matter changes, neuroimaging
- MeSH terms
- Age Factors, Brain, Demyelinating Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Schizophrenia, Anisotropy, Cell Death, Protein Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review